跳至主要内容
临床试验/JPRN-UMIN000028630
JPRN-UMIN000028630已完成1 期

A Phase I/II trial of focal carbon-ion radiotherapy using 4 fractions for the patients with local recurrence prostate cancer after radiotherapy - Carbon-ion radiotherapy for local recurrence prostate cancer

QST Hospital, National Institutes for Quantum Science and Technology Treatment division0 个研究点目标入组 20 人开始时间: 2017年8月29日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Other salvage therapy has been performed except for the case with positive local recurrence by biopsy after discontinuance of hormonal therapy 2) Presence of biopsy proven separate lesions except for visible lesion in MRI. 3) Having at least one factor of GS>9, T3b and PSA > 40 ng/ml before initial radical radiotherapy. 4) occuring Grade 3 or more severe adverse effect after initial radical radiotherapy. 5) Ineligible dose constraint of risk organs 6) Considered to be castration resistant prostate cancer 7) Presence of active double cancer

研究者

发起方
QST Hospital, National Institutes for Quantum Science and Technology Treatment division

相似试验